Description
CJC-1295 Without DAC 5mg + Ipamorelin 5mg Blend
Dual-Peptide Research Blend | 10mg Total Peptide Material
The CJC-1295 Without DAC 5mg + Ipamorelin 5mg Blend combines two distinct peptide research compounds in a single formulation. The product formulation indicated by the URL contains 5mg of CJC-1295 Without DAC and 5mg of Ipamorelin, providing a stated total of 10mg peptide material.
CJC-1295 Without DAC is a peptide related to the growth hormone-releasing hormone (GHRH) analogue research area. PubChem records the compound with molecular formula C₁₅₂H₂₅₂N₄₄O₄₂ and molecular weight approximately 3367.9 g/mol.
Ipamorelin is a synthetic pentapeptide and ghrelin-receptor agonist used in research involving growth-hormone secretagogue pathways. PubChem lists its molecular formula as C₃₈H₄₉N₉O₅ and molecular weight as approximately 711.9 g/mol.
Because these compounds have different molecular structures and mechanisms of receptor interaction, researchers should characterize each component separately when evaluating the blend.
CJC-1295 Without DAC + Ipamorelin Research Profile
First, CJC-1295 Without DAC belongs to the GHRH-related peptide research area. Researchers can investigate its molecular structure, peptide identity, purity, and analytical properties using suitable laboratory methods.
Next, Ipamorelin is a defined pentapeptide with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH₂. Researchers can study its peptide structure, molecular characteristics, purity, and receptor-related properties.
Therefore, this product should be documented as a two-component peptide blend, rather than as a single chemical compound.
CJC-1295 Without DAC 5mg + Ipamorelin 5mg Composition
| Component | Quantity |
|---|---|
| CJC-1295 Without DAC | 5mg |
| Ipamorelin | 5mg |
| Total Peptide Material | 10mg |
The quantities above are based on the product name/URL. However, the exact salt form, purity, formulation, and batch characteristics should be verified against the product label and batch-specific Certificate of Analysis.
CJC-1295 Without DAC Research Profile
CJC-1295 Without DAC is a defined peptide compound recorded by PubChem under CID 91976842. PubChem reports its molecular formula as C₁₅₂H₂₅₂N₄₄O₄₂ and molecular weight as 3367.9 g/mol.
Researchers may examine the compound for:
- Peptide identity
- Molecular characterization
- Purity and assay
- Structural analysis
- Peptide stability
- Analytical method development
- Comparative peptide research
Ipamorelin Research Profile
Ipamorelin is a synthetic pentapeptide with the documented sequence Aib-His-D-2-Nal-D-Phe-Lys-NH₂. PubChem classifies /product/cjc-1295-without…mg-ipa-5mg-blend/ it as a peptide and ghrelin mimetic associated with growth-hormone secretagogue activity.
Researchers may evaluate Ipamorelin for:
- Peptide sequence characterization
- Molecular identification
- Receptor-related research
- Purity analysis
- Stability studies
- Analytical characterization
- Comparative peptide research
Research Applications
Researchers may investigate the combined formulation in controlled laboratory studies involving:
- Peptide chemistry
- GHRH-related research
- Growth-hormone secretagogue research
- Receptor biology
- Molecular characterization
- Analytical chemistry
- Purity and assay testing
- Peptide stability
- Formulation research
- Comparative peptide analysis
In addition, laboratories can analyze CJC-1295 Without DAC and Ipamorelin individually before evaluating the complete formulation.
Key Characteristics
Two-Component Peptide Blend
The formulation combines CJC-1295 Without DAC and Ipamorelin in one research preparation.
Defined Component Quantities
The stated formulation contains 5mg of each peptide, giving a total of 10mg peptide material.
Distinct Molecular Identities
Each component has a different sequence and molecular structure. Consequently, researchers should apply appropriate component-specific analytical methods.
Analytical Research Utility
Laboratories may evaluate the blend for identity, purity, molecular mass, concentration, stability, and degradation characteristics.
Product Specifications
Product Name: CJC-1295 Without DAC 5mg + Ipamorelin 5mg Blend
CJC-1295 Without DAC: 5mg
Ipamorelin: 5mg
Total Peptide Material: 10mg
Product Type: Dual-peptide research blend
CJC-1295 Without DAC Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
CJC-1295 Without DAC Molecular Weight: 3367.9 g/mol
Ipamorelin Molecular Formula: C₃₈H₄₉N₉O₅
Ipamorelin Molecular Weight: 711.9 g/mol
Intended Application: Laboratory and analytical research
Quality & Documentation
Research-material documentation may include:
- Individual peptide identity
- Sequence information
- Component quantities
- Purity or assay
- Molecular-weight information
- Batch or lot number
- Certificate of Analysis (COA)
- Analytical testing
- Stability information
- Product specifications
Furthermore, the product label and batch-specific COA should remain the primary reference for the exact material supplied.
Analytical Characterization
Because the formulation contains two different peptides, researchers may assess each component separately.
Depending on the research protocol, analysis may include:
- Identity confirmation
- Purity analysis
- Molecular-mass determination
- Concentration assessment
- Stability testing
- Degradation analysis
- Formulation characterization
This approach helps researchers distinguish the analytical properties of each peptide within the blend.
CJC-1295 Without DAC and Ipamorelin Identification
CJC-1295 Without DAC and Ipamorelin are separate peptide entities. Therefore, research results for one compound should not automatically be applied to the other or to the combined formulation.
Current research literature also distinguishes CJC-1295 and Ipamorelin as different peptide classes within the broader growth-hormone/IGF-1 research area.
Important Research Information
This product is presented as a two-component peptide research formulation for laboratory and analytical applications.
However, peptide identity, purity, concentration, formulation, and batch characteristics can vary. Therefore, always use the manufacturer’s documentation and applicable batch-specific analytical data as the primary reference.
This information is intended for scientific, analytical, compound-identification, and legitimate laboratory research purposes. It does not provide dosing, administration, treatment, or performance-enhancement instructions.

Leave a Reply